532296 announcements Glenmark Pha announcements and dividends declared BSE
Glenmark Pha Complete list of announcements declared & dividend announcements by Glenmark Pha 532296
Glenmark Pha 532296 listed on BSE and deals inAnnouncements and dividends declared by Glenmark Pha 532296
Eris Lifesciences to buy some dermatology brands from Glenmark Pharma
The deal for the portfolio that has an annual revenue base of 850 million rupees, will be financed through borrowings, and the transaction is expected to achieve financial closure very soon, Eris said
Announcement as on 17 January 2023
Glenmark Pharmaceuticals launches generic version of diuretic Bumetanide injection
The launch affirms commitment to Glenmark's continued focus on institutional business, company Senior Vice President, Business Development Portfolio, Product Launch & Strategy, Vijay Raghavan said. The Bumex injection, 0.25 mg/mL achieved annual sales of a
Announcement as on 10 January 2023
F&O Call: Nandish Shah recommends to long Glenmark Pharma futures
The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.
Announcement as on 06 January 2023
Glenmark Pharmaceuticals rises 5% on launching first 3-drug FDC for type-2 diabetes in India
“This FDC has been launched under the brand name Zita®-PioMet,†the company said in a BSE filing. “This offers patients with Type 2 diabetes the convenience of once-daily dosing to improve their glycemic control and achieve the targeted HbA1c within
Announcement as on 21 December 2022
Glenmark Pharma launches combination drug for Type 2 diabetic patients
Glenmark Pharmaceuticals Ltd on Wednesday said it has launched triple fixed-dose combination Teneligliptin with Pioglitazone and Metformin in India for diabetic patients. This fixed-dose combination offers patients with Type 2 diabetes the convenience of o
Announcement as on 21 December 2022
Announcements by Glenmark Pha first page | Next page | Prev page |
532296 Glenmark Pha current price & indicator signals
Recent prices of 532296 Glenmark Pha are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 15 Fri May 2026 | 2324.95 | 2317.90 to 2366.90 | -0.66% | 0.36 times |
| 14 Thu May 2026 | 2340.30 | 2294.65 to 2350.00 | 2.73% | 0.91 times |
| 13 Wed May 2026 | 2278.20 | 2236.10 to 2326.35 | 1% | 0.42 times |
| 12 Tue May 2026 | 2255.55 | 2245.00 to 2338.70 | -4.03% | 2.63 times |
| 11 Mon May 2026 | 2350.15 | 2320.00 to 2368.30 | -0.6% | 0.38 times |
| 08 Fri May 2026 | 2364.35 | 2315.35 to 2384.45 | -0.28% | 0.44 times |
| 07 Thu May 2026 | 2371.05 | 2356.80 to 2404.00 | -0.11% | 1.07 times |
| 06 Wed May 2026 | 2373.75 | 2356.25 to 2439.70 | -1.91% | 2.14 times |
| 05 Tue May 2026 | 2420.05 | 2361.85 to 2431.00 | 1.15% | 0.73 times |
| 04 Mon May 2026 | 2392.60 | 2384.75 to 2448.25 | -0.54% | 0.53 times |
| 30 Thu Apr 2026 | 2405.55 | 2389.60 to 2454.95 | -0.21% | 0.75 times |
| 29 Wed Apr 2026 | 2410.60 | 2404.00 to 2471.05 | 0.23% | 1.42 times |
Videos related to: 532296 announcements Glenmark Pha announcements and dividends declared BSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance


